Comparative Pharmacokinetic Study of Three Abatacept Products in Male Normal Healthy Volunteers by the Subcutaneous Route
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
This is a randomised, double-blind, single dose, parallel groups study to compare the PK,
immunogenicity, and safety of 3 abatacept products (DRL_AB, RP and RMP) in male NHV.